Clinical Trial Detail

NCT ID NCT02098109
Title Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Washington University School of Medicine
Indications

non-Hodgkin lymphoma

multiple myeloma

Therapies

Plerixafor

Filgrastim

Age Groups: adult

No variant requirements are available.